TCG Crossover GP II, LLC 13D and 13G filings for Fulcrum Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-20 4:21 pm Purchase | 2024-09-12 | 13G | Fulcrum Therapeutics, Inc. FULC | TCG Crossover GP II, LLC | 5,000,000 9.400% | 5,000,000 (New Position) | Filing |